Gufic Biosciences Ltd has been allotted 512,000 equity shares of its subsidiary Gufic Prime Private Limited for Rs. 5,12,000 through a rights issue on July 14, 2025, increasing its shareholding to 60%. Gufic Prime is a pharmaceutical company that has yet to commence business operations.